Jazz Pharmaceuticals plc (JAZZ) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: $15.93M2010: $57.79M2011: $127.83M2012: $197.84M2013: $340.31M2014: $195.59M2015: $508.22M2016: $591.65M2017: $528.84M2018: $614.84M2019: $532.37M2020: $378.07M2021: $170.28M2022: -$65.53M2023: $578.58M2024: $716.63M2025: -$430.24M-$430.24M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$430.24M-160.0%
2024$716.63M+23.9%
2023$578.58M+983.0%
2022-$65.53M-138.5%
2021$170.28M-55.0%
2020$378.07M-29.0%
2019$532.37M-13.4%
2018$614.84M+16.3%
2017$528.84M-10.6%
2016$591.65M+16.4%
2015$508.22M+159.8%
2014$195.59M-42.5%
2013$340.31M+72.0%
2012$197.84M+54.8%
2011$127.83M+121.2%
2010$57.79M+262.8%
2009$15.93M